A subscription to JoVE is required to view this content. Sign in or start your free trial.

Method Article

Analysis of Lymphocyte Extravasation Using an In Vitro Model of the Human Blood-brain Barrier

19.7K views

⸱

DOI:

10.3791/55390

⸱

April 5th, 2017

 ,  ,  ,  ,  , 

* These authors contributed equally

In This Article

Summary

Here, we describe a human blood-brain barrier model enabling to investigate lymphocyte transmigration into the central nervous system in vitro.

Abstract

Lymphocyte extravasation into the central nervous system (CNS) is critical for immune surveillance. Disease-related alterations of lymphocyte extravasation might result in pathophysiological changes in the CNS. Thus, investigation of lymphocyte migration into the CNS is important to understand inflammatory CNS diseases and to develop new therapy approaches. Here we present an in vitro model of the human blood-brain barrier to study lymphocyte extravasation. Human brain microvascular endothelial cells (HBMEC) are confluently grown on a porous polyethylene terephthalate transwell insert to mimic the endothelium of the blood-brain barrier. Barrier function is validated by zonula occludens immunohistochemistry, transendothelial electrical resistance (TEER) measurements as well as analysis of evans blue permeation. This model allows investigation of the diapedesis of rare lymphocyte subsets such as CD56brightCD16dim/- NK cells. Furthermore, the effects of other cells, cytokines and chemokines, disease-related alterations, and distinct treatment regimens on the migratory capacity of lymphocytes can be studied. Finally, the impact of inflammatory stimuli as well as different treatment regimens on the endothelial barrier can be analyzed.

Introduction

Lymphocyte migration from the blood into tissues is crucial for immune surveillance. A sequence of specific molecular interactions ensures site specific extravasation into small intestine, skin, lymph nodes, the central nervous system (CNS), and other tissues1. Alterations in lymphocyte migration are involved in the pathophysiology of a number of wide spread diseases2. Migration into the immune-privileged CNS is tightly regulated and accordingly alterations of this process are involved in CNS-related diseases like encephalomyelitis3, neuromyelitis optica, stroke, and multiple sclerosis (MS)

Access restricted. Please log in or start a trial to view this content.

Protocol

1. Cell Culture of Human Brain Microvascular Endothelial Cells (HBMEC)

  1. Coating of cell culture flasks
    1. To prepare the fibronectin solution, add 10 mL PBS to a 15 mL centrifuge tube. Add 150 µL fibronectin and mix well.
    2. To cover the bottom a T-25 cell culture flask add 2 mL of the fibronectin solution. Incubate the cell culture flask for at least 3 h at 37 °C in the incubator. Fibronectin coated flasks can be stored for 2 weeks at 37 °C / 5% CO2.
  2. Seeding and cell culture of HBMEC
    1. Aspirate fibronectin solution from the bottom of the cell culture flask. Add 7.2 x 104 HBMEC/cm² sus....

Access restricted. Please log in or start a trial to view this content.

Results

Representative results showing transmigration of NK-cell and T-cell subsets using the human blood-brain barrier model (Figure 1A) are shown. The integrity of the HBMEC monolayer was validated by staining of the tight junction molecule ZO-1, transendothelial electrical resistance (TEER) measurements, and evans blue permeation (Figure 1B). Following 3 - 4 days culture HBMEC expressed the tight junction molecule ZO-1 (Figure 1B, left). Furth.......

Access restricted. Please log in or start a trial to view this content.

Discussion

Here we present a technique to investigate the transmigration of lymphocytes across the human blood-brain barrier. In vitro analysis of lymphocyte migration to the CNS is important to study basic processes of lymphocyte extravasation, potential disease-related alterations, and new therapeutic approaches.

Several modifications of the blood-brain barrier model are possible. For example, cells from the upper compartment could be analyzed to investigate the composition of the non-migrated.......

Access restricted. Please log in or start a trial to view this content.

Disclosures

The author(s) declared the following potential conflicts of interest with respect to the research, authorship, and/or publication of this article: A.S.-M. and U.B. have no financial disclosures. T. S.-H. received travel and conference expenses from Biogen. N.S. received speaker and advisory board honoraria from Biogen and Novartis Pharma, as well as travel expenses from Biogen. H.W. received compensation for serving on Scientific Advisory Boards/Steering Committees for Bayer Healthcare, Biogen, Merck Serono, Novartis, and Sanofi-Genzyme. He also received speaker honoraria and travel support from Bayer Vital GmbH, Bayer Schering AG, Biogen, CSL Behring, Fresenius Medical Care, Glaxo Smith Kline, GW Pharmaceuticals, Lundbeck, Merck Serono, Omniamed, Novartis, and Sanofi-Genzyme. He received compensation as a consultant from Biogen, Merck Serono, Novartis, and Sanofi-Genzyme. H.W. received research support from Bayer Vital, Biogen, Genzyme, Merck Serono, Novartis, Sanofi-Aventis Germany, and Sanofi US. C.C.G. received speaker honoraria and travel expenses for attending meetings from Genzyme, Novartis Pharma GmbH, and Bayer Health Care.

Acknowledgements

This study has been supported by the Collaborative Research Centre CRC TR128 "Initiating/Effector versus Regulatory Mechanisms in Multiple Sclerosis-Progress towards Tackling the Disease" (Project A9 to H.W. and C.C.G., project B1 to N.S.).

....

Access restricted. Please log in or start a trial to view this content.

Materials

List of materials used in this article
NameCompanyCatalog NumberComments
PBSGibco14190-094without CaCl2 or MgCl2
Fibronectin 1 mg/mLSigmaF1141-5MGfrom bovine plasma
T-25 cell culture flaskGreiner BioOne690160
HBMECScienCell1000
PelobiotechPB-H-6023
AccutaseSigmaA6964-100ML
ECM-bScienCell1001-b
FBSScienCell1001-b
Penicillin/StreptomycinScienCell1001-b
Endothelial cell growth supplementScienCell1001-b
TranswellCorning3472clear, 6.5 mm diameter, 3.0 µm pore size
96-well flat bottom plateCorning3596
Evans blueSigmaE2129-10Gstock solution: 1 g/50 mL PBS
B27Gibco17504-04450x concentrated
Infinite M200ProTecan
96-well black flat bottom plateGreiner BioOne675086
48-well plateCorning3526
RPMI 1640Gibco61870-010
Flow Count FluorospheresBeckman Coulter7547053
Na-EDTASigmaE5134
BSASigmaA2153
Gallios 10-color flow cytometerBeckman Coulter
Kaluza 1.5aBeckman Coulter
TNF-αPeprotech300-01A
IFN-γPeprotech300-02
CD3-PerCP/Cy5.5Biolegend300430clone UCHT1
CD56-PC7Beckman CoulterA21692clone N901
CD16-A750Beckman CoulterA66330clone 3G8
CD4-FITCBiolegend300506clone RPA-T4
CD8-A700Beckman CoulterA66332clone B9.11

References

  1. Ransohoff, R. M., Kivisakk, P., Kidd, G. Three or more routes for leukocyte migration into the central nervous system. Nat Rev Immunol. 3 (7), 569-581 (2003).
  2. Takeshita, Y., et al. An in vitro blood-brain barrier model combining shear stress and endothelial cell/astrocyte co-culture. J Neurosci Methods. 232, 165-1....

Access restricted. Please log in or start a trial to view this content.

Reprints and Permissions

Explore More Articles

Human Brain Microvascular Endothelial CellsTransendothelial Electrical ResistanceEvans Blue PermeationFlow Cytometry AnalysisCD56bright CD16dim NK CellsInterferon Gamma TNF AlphaStromal Vascular Fraction IsolationCell Culture Insert Preparation